Aromatase inhibitors: the journey from the state of the art to clinical open questions.

Front Oncol · 2023 · PMC10770835 · PMID 38188305

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Moreover, all the trials commencing endocrine treatment with an AI showed, collectively, a highly significant drop of 30% in recurrence during years 0 to 1, confirming the superiority of AIs over TAM ( 28 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.